0001246360-13-003768.txt : 20130731 0001246360-13-003768.hdr.sgml : 20130731 20130731172813 ACCESSION NUMBER: 0001246360-13-003768 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20130729 FILED AS OF DATE: 20130731 DATE AS OF CHANGE: 20130731 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: MEDTRONIC INC CENTRAL INDEX KEY: 0000064670 STANDARD INDUSTRIAL CLASSIFICATION: ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS [3845] IRS NUMBER: 410793183 STATE OF INCORPORATION: MN FISCAL YEAR END: 0429 BUSINESS ADDRESS: STREET 1: 710 MEDTRONIC PKWY STREET 2: MS LC300 CITY: MINNEAPOLIS STATE: MN ZIP: 55432 BUSINESS PHONE: 7635144000 MAIL ADDRESS: STREET 1: 710 MEDTRONIC PKWY CITY: MINNEAPOLIS STATE: MN ZIP: 55432 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: OConnell Christopher J CENTRAL INDEX KEY: 0001379946 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-07707 FILM NUMBER: 131000062 MAIL ADDRESS: STREET 1: MEDTRONIC, INC. STREET 2: 710 MEDTRONIC PKWY CITY: MINNEAPOLIS STATE: MN ZIP: 55432 4 1 form.xml PRIMARY DOCUMENT X0306 4 2013-07-29 false 0000064670 MEDTRONIC INC MDT 0001379946 OConnell Christopher J 710 MEDTRONIC PKWY MS LC300 MINNEAPOLIS MN 55432 false true false false EVP & GroupPres Restora Therap Common Stock 2582.395 I ESOP Common Stock 2013-07-29 4 A false 15058 0 A 132711.798 D Employee Stock Option (right to buy) 55.32 2013-07-29 4 A false 1808 0 A 2014-07-29 2023-07-29 Common Stock 1808 1808 D Employee Stock Option (right to buy) 55.32 2013-07-29 4 A false 60250 0 A 2014-07-29 2023-07-29 Common Stock 60250 62058 D These options become exercisable at the rate of 25% of the shares granted per year beginning on the first anniversary of grant. This balance increased by 433.661 due to exempt transactions such as dividend reinvestment. The restrictions on such units shall lapse 100% on the third anniversary of the Grant Date if the Companys cumulative diluted earnings per share growth during the 36 month period ending on the last day of the Companys fiscal year 2016 equals or exceeds a 3% compound annual growth rate, as determined by the Compensation Committee. Rhonda L. Ingalsbe, Attorney-in-fact 2013-07-31